ACYLATED PIPERAZINE DERIVATIVES AS MELANOCORTIN-4 RECEPTOR AGONISTS
Certain novel N-acylated piperazine derivatives are agonists of the human melanocortin receptor(s) and, in particular, are selective agonists of the human melanocortin-4 receptor (MC-4R). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the...
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | BAKSHI, RAMAN, K HONG, QINGMEI SEBHAT, IYASSU, K YE, ZHIXIONG NARGUND, RAVI, P POLLARD, PATRICK, G UJJAINWALLA, FEROZE |
description | Certain novel N-acylated piperazine derivatives are agonists of the human melanocortin receptor(s) and, in particular, are selective agonists of the human melanocortin-4 receptor (MC-4R). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the activation of MC-4R, such as obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction.
Selon l'invention, certains dérivés de pipérazine N-acylés sont des agonistes du ou des récepteurs de la mélanocortine humains, et, plus particulièrement, des agonistes sélectifs du récepteur de la mélanocortine 4 (MC-4R) humain. Par conséquent, ils sont utiles pour traiter, contrôler ou prévenir des maladies et des troubles réactifs à l'activation de MC-4R, tels que l'obésité, le diabète et la dysfonction sexuelle, y compris le dysfonctionnement érectile et la dysfonction sexuelle féminine. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2004078716A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2004078716A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2004078716A13</originalsourceid><addsrcrecordid>eNrjZHB2dI70cQxxdVEI8AxwDXKM8vRzVXBxDfIMcwzxDHMNVnAMVvB19XH083f2Dwrx9NM1UQhydXYNCPEPUnB09_fzDA4J5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgYGJgbmFuaGZo6GxsSpAgD5lyyw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ACYLATED PIPERAZINE DERIVATIVES AS MELANOCORTIN-4 RECEPTOR AGONISTS</title><source>esp@cenet</source><creator>BAKSHI, RAMAN, K ; HONG, QINGMEI ; SEBHAT, IYASSU, K ; YE, ZHIXIONG ; NARGUND, RAVI, P ; POLLARD, PATRICK, G ; UJJAINWALLA, FEROZE</creator><creatorcontrib>BAKSHI, RAMAN, K ; HONG, QINGMEI ; SEBHAT, IYASSU, K ; YE, ZHIXIONG ; NARGUND, RAVI, P ; POLLARD, PATRICK, G ; UJJAINWALLA, FEROZE</creatorcontrib><description>Certain novel N-acylated piperazine derivatives are agonists of the human melanocortin receptor(s) and, in particular, are selective agonists of the human melanocortin-4 receptor (MC-4R). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the activation of MC-4R, such as obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction.
Selon l'invention, certains dérivés de pipérazine N-acylés sont des agonistes du ou des récepteurs de la mélanocortine humains, et, plus particulièrement, des agonistes sélectifs du récepteur de la mélanocortine 4 (MC-4R) humain. Par conséquent, ils sont utiles pour traiter, contrôler ou prévenir des maladies et des troubles réactifs à l'activation de MC-4R, tels que l'obésité, le diabète et la dysfonction sexuelle, y compris le dysfonctionnement érectile et la dysfonction sexuelle féminine.</description><edition>7</edition><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2004</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20040916&DB=EPODOC&CC=WO&NR=2004078716A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20040916&DB=EPODOC&CC=WO&NR=2004078716A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BAKSHI, RAMAN, K</creatorcontrib><creatorcontrib>HONG, QINGMEI</creatorcontrib><creatorcontrib>SEBHAT, IYASSU, K</creatorcontrib><creatorcontrib>YE, ZHIXIONG</creatorcontrib><creatorcontrib>NARGUND, RAVI, P</creatorcontrib><creatorcontrib>POLLARD, PATRICK, G</creatorcontrib><creatorcontrib>UJJAINWALLA, FEROZE</creatorcontrib><title>ACYLATED PIPERAZINE DERIVATIVES AS MELANOCORTIN-4 RECEPTOR AGONISTS</title><description>Certain novel N-acylated piperazine derivatives are agonists of the human melanocortin receptor(s) and, in particular, are selective agonists of the human melanocortin-4 receptor (MC-4R). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the activation of MC-4R, such as obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction.
Selon l'invention, certains dérivés de pipérazine N-acylés sont des agonistes du ou des récepteurs de la mélanocortine humains, et, plus particulièrement, des agonistes sélectifs du récepteur de la mélanocortine 4 (MC-4R) humain. Par conséquent, ils sont utiles pour traiter, contrôler ou prévenir des maladies et des troubles réactifs à l'activation de MC-4R, tels que l'obésité, le diabète et la dysfonction sexuelle, y compris le dysfonctionnement érectile et la dysfonction sexuelle féminine.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2004</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHB2dI70cQxxdVEI8AxwDXKM8vRzVXBxDfIMcwzxDHMNVnAMVvB19XH083f2Dwrx9NM1UQhydXYNCPEPUnB09_fzDA4J5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgYGJgbmFuaGZo6GxsSpAgD5lyyw</recordid><startdate>20040916</startdate><enddate>20040916</enddate><creator>BAKSHI, RAMAN, K</creator><creator>HONG, QINGMEI</creator><creator>SEBHAT, IYASSU, K</creator><creator>YE, ZHIXIONG</creator><creator>NARGUND, RAVI, P</creator><creator>POLLARD, PATRICK, G</creator><creator>UJJAINWALLA, FEROZE</creator><scope>EVB</scope></search><sort><creationdate>20040916</creationdate><title>ACYLATED PIPERAZINE DERIVATIVES AS MELANOCORTIN-4 RECEPTOR AGONISTS</title><author>BAKSHI, RAMAN, K ; HONG, QINGMEI ; SEBHAT, IYASSU, K ; YE, ZHIXIONG ; NARGUND, RAVI, P ; POLLARD, PATRICK, G ; UJJAINWALLA, FEROZE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2004078716A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2004</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>BAKSHI, RAMAN, K</creatorcontrib><creatorcontrib>HONG, QINGMEI</creatorcontrib><creatorcontrib>SEBHAT, IYASSU, K</creatorcontrib><creatorcontrib>YE, ZHIXIONG</creatorcontrib><creatorcontrib>NARGUND, RAVI, P</creatorcontrib><creatorcontrib>POLLARD, PATRICK, G</creatorcontrib><creatorcontrib>UJJAINWALLA, FEROZE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BAKSHI, RAMAN, K</au><au>HONG, QINGMEI</au><au>SEBHAT, IYASSU, K</au><au>YE, ZHIXIONG</au><au>NARGUND, RAVI, P</au><au>POLLARD, PATRICK, G</au><au>UJJAINWALLA, FEROZE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ACYLATED PIPERAZINE DERIVATIVES AS MELANOCORTIN-4 RECEPTOR AGONISTS</title><date>2004-09-16</date><risdate>2004</risdate><abstract>Certain novel N-acylated piperazine derivatives are agonists of the human melanocortin receptor(s) and, in particular, are selective agonists of the human melanocortin-4 receptor (MC-4R). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the activation of MC-4R, such as obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction.
Selon l'invention, certains dérivés de pipérazine N-acylés sont des agonistes du ou des récepteurs de la mélanocortine humains, et, plus particulièrement, des agonistes sélectifs du récepteur de la mélanocortine 4 (MC-4R) humain. Par conséquent, ils sont utiles pour traiter, contrôler ou prévenir des maladies et des troubles réactifs à l'activation de MC-4R, tels que l'obésité, le diabète et la dysfonction sexuelle, y compris le dysfonctionnement érectile et la dysfonction sexuelle féminine.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; fre |
recordid | cdi_epo_espacenet_WO2004078716A1 |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | ACYLATED PIPERAZINE DERIVATIVES AS MELANOCORTIN-4 RECEPTOR AGONISTS |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T17%3A42%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BAKSHI,%20RAMAN,%20K&rft.date=2004-09-16&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2004078716A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |